DE3469026D1 - Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them - Google Patents

Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them

Info

Publication number
DE3469026D1
DE3469026D1 DE8484400157T DE3469026T DE3469026D1 DE 3469026 D1 DE3469026 D1 DE 3469026D1 DE 8484400157 T DE8484400157 T DE 8484400157T DE 3469026 T DE3469026 T DE 3469026T DE 3469026 D1 DE3469026 D1 DE 3469026D1
Authority
DE
Germany
Prior art keywords
psychotrope
intermediates
activity
preparation
pyridazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484400157T
Other languages
English (en)
Inventor
Kathleen Biziere
Jean-Paul Kan
Camille-Georges Wermuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8301366A external-priority patent/FR2540115B1/fr
Priority claimed from FR8318433A external-priority patent/FR2555178B1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3469026D1 publication Critical patent/DE3469026D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE8484400157T 1983-01-28 1984-01-25 Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them Expired DE3469026D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301366A FR2540115B1 (fr) 1983-01-28 1983-01-28 Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
FR8318433A FR2555178B1 (fr) 1983-11-18 1983-11-18 Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
DE3469026D1 true DE3469026D1 (en) 1988-03-03

Family

ID=26223263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484400157T Expired DE3469026D1 (en) 1983-01-28 1984-01-25 Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them

Country Status (25)

Country Link
US (2) US4565814A (de)
EP (1) EP0116494B1 (de)
KR (1) KR910000639B1 (de)
AU (1) AU566352B2 (de)
CA (1) CA1218655A (de)
CS (1) CS274405B2 (de)
DD (1) DD215542A5 (de)
DE (1) DE3469026D1 (de)
DK (3) DK159969C (de)
ES (1) ES8500253A1 (de)
FI (1) FI77453C (de)
GR (1) GR81682B (de)
HU (1) HU192975B (de)
IE (1) IE56750B1 (de)
IL (1) IL70755A (de)
MA (1) MA20019A1 (de)
NO (1) NO840329L (de)
NZ (1) NZ206957A (de)
OA (1) OA07645A (de)
PH (1) PH21476A (de)
PL (1) PL143994B1 (de)
PT (1) PT77994B (de)
SG (1) SG9389G (de)
SU (1) SU1274623A3 (de)
YU (1) YU14184A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
ES8707201A1 (es) * 1985-06-14 1987-07-16 Lilly Co Eli Un procedimiento para la preparacion de una serie de piridazinas
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
NZ509748A (en) * 1998-08-20 2003-01-31 Toyama Chemical Co Ltd Nitrogenous heterocyclic carboxamide derivatives or salts useful as antiviral agents
NZ529822A (en) * 1999-01-22 2005-11-25 Elan Pharm Inc Acyl derivatives which treat VLA-4 related disorders
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
AU2005260102A1 (en) * 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
EP1741709A1 (de) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka
CN101273035A (zh) 2005-09-29 2008-09-24 伊兰制药公司 抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物
DK1940826T3 (da) 2005-09-29 2011-04-18 Elan Pharm Inc Pyrimidinylamidforbindelser, der inhiberer leukocytadhæsion medieret gennem BLA-4
MX2008010988A (es) 2006-02-27 2008-10-20 Elan Pharm Inc Compuestos de pirimidinil sulfonamida que inhiben la adhesion de los leucocitos mediada por vla-4.
CA2760151A1 (en) 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant

Also Published As

Publication number Publication date
DD215542A5 (de) 1984-11-14
OA07645A (fr) 1985-05-23
DK162219B (da) 1991-09-30
AU566352B2 (en) 1987-10-15
EP0116494A1 (de) 1984-08-22
PL245932A1 (en) 1985-05-21
DK621589D0 (da) 1989-12-08
KR910000639B1 (ko) 1991-01-31
CA1218655A (en) 1987-03-03
FI840349A (fi) 1984-07-29
MA20019A1 (fr) 1984-10-01
DK25984A (da) 1984-07-29
HU192975B (en) 1987-08-28
SU1274623A3 (ru) 1986-11-30
FI840349A0 (fi) 1984-01-27
IL70755A (en) 1987-03-31
NO840329L (no) 1984-07-30
SG9389G (en) 1989-07-07
DK159969B (da) 1991-01-07
CS274405B2 (en) 1991-04-11
DK621689A (da) 1989-12-08
PT77994A (fr) 1984-02-01
CS61484A2 (en) 1990-09-12
YU14184A (en) 1986-10-31
ES529108A0 (es) 1984-10-01
DK162219C (da) 1992-03-02
KR840007587A (ko) 1984-12-08
FI77453C (fi) 1989-03-10
DK159969C (da) 1991-05-27
DK162218C (da) 1992-03-02
PH21476A (en) 1987-10-28
ES8500253A1 (es) 1984-10-01
NZ206957A (en) 1987-06-30
IE56750B1 (en) 1991-12-04
US4565814A (en) 1986-01-21
US4631280A (en) 1986-12-23
AU2372884A (en) 1984-08-02
FI77453B (fi) 1988-11-30
EP0116494B1 (de) 1988-01-27
DK621689D0 (da) 1989-12-08
PL143994B1 (en) 1988-04-30
DK162218B (da) 1991-09-30
PT77994B (fr) 1986-04-10
IE840148L (en) 1984-07-28
GR81682B (de) 1984-12-12
DK621589A (da) 1989-12-08
IL70755A0 (en) 1984-04-30
DK25984D0 (da) 1984-01-20

Similar Documents

Publication Publication Date Title
EP0161632A3 (en) Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates
DE3572488D1 (en) Dialkoxyridines, process for their preparation, their application and medicaments containing them
ZA865374B (en) Tertiary hydroxyalkylxanthines,process for their preparation,medicaments containing them and their use
DE3560511D1 (en) Pleuromutilin derivatives, process for their preparation and their use
DE3469026D1 (en) Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them
SG93690G (en) Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them
PT82307A (en) 4-demethyl-4-epipodophyllotoxin derivatives a process for their preparation and their use as medicaments
AR243877A1 (es) Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento.
PT83548A (en) Process for preparing piperazinoisothiazolones with psychotropic activity
ZA843722B (en) Dibenzodiazepin derivatives,a process for their preparation and their use as medicaments
ZA868065B (en) Antihypertensive thieno-isoxazoles and-pyrazoles,a process and intermediates for their preparation and their use as medicaments
AU588644B2 (en) A silver catalyst and a process for preparing same
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
CS382191A3 (en) Benzoxazol- and benzothiazolamine derivatives, process of their preparation and pharmaceuticals based thereon
IL64907A (en) Pyrrolobenzodiazepinones,a process for their preparation,their use,and medicaments containing them
ZA856775B (en) Histargin-related compounds,a process for their preparation and their use as medicaments
DE3571978D1 (en) Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them
EP0287977A3 (en) Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments
ZA851190B (en) Pleuromutilin derivatives,process for their preparation and their use
IL76273A0 (en) Pseudooligosaccharides with an alpha-glucosidase-inhibiting action,a process for their preparation,their use and pharmaceutical products
PT82427A (en) Ethanobenzazepines a process and intermediates for their preparation and their use as medicaments
PT80276B (en) Substituted 1-aminoalkylamino-4-aryloxypiperidines a process for their preparation intermediates thereof and their use as medicaments
ZA823950B (en) 4-amino-benzylamine derivatives,a process for their preparation and their use as pharmaceuticals
ZA851793B (en) Carboxyalkyldipeptide derivatives,a process for their preparation,agents containing them,and their use
ZA866444B (en) Spergualin-related compounds,a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee